PDB58 WHAT IS THE IMPACT OF GENERIC SUBSTITUTION OF ROSIGLITAZONE ON PATIENT OUTCOMES AND TREATMENT COSTS? AN HMO EXPERIENCE
May 1, 2011, 00:00
10.1016/j.jval.2011.02.566
https://www.valueinhealthjournal.com/article/S1098-3015(11)00705-4/fulltext
Title :
PDB58 WHAT IS THE IMPACT OF GENERIC SUBSTITUTION OF ROSIGLITAZONE ON PATIENT OUTCOMES AND TREATMENT COSTS? AN HMO EXPERIENCE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)00705-4&doi=10.1016/j.jval.2011.02.566
First page :
A101
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
20